MINOIA, Mariella
 Distribuzione geografica
Continente #
NA - Nord America 1.812
EU - Europa 420
AS - Asia 354
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 2.593
Nazione #
US - Stati Uniti d'America 1.812
CN - Cina 205
UA - Ucraina 125
DE - Germania 110
TR - Turchia 75
SG - Singapore 68
GB - Regno Unito 54
IT - Italia 51
SE - Svezia 33
FI - Finlandia 32
RU - Federazione Russa 10
BE - Belgio 5
BR - Brasile 2
EU - Europa 2
ID - Indonesia 2
VN - Vietnam 2
CL - Cile 1
EC - Ecuador 1
IN - India 1
IR - Iran 1
NZ - Nuova Zelanda 1
Totale 2.593
Città #
Woodbridge 246
Chandler 184
Fairfield 178
Houston 170
Ashburn 167
Jacksonville 147
Wilmington 82
Ann Arbor 81
Seattle 73
Cambridge 64
Singapore 55
Addison 47
Izmir 42
Nanjing 37
Princeton 30
Shanghai 28
Dearborn 27
Beijing 25
Boardman 25
Bremen 23
Ferrara 20
Milan 19
Shenyang 16
Jinan 13
Nanchang 13
Changsha 12
San Diego 11
New York 10
Santa Clara 10
Tianjin 10
Falls Church 8
Hebei 7
Mountain View 7
Indiana 6
Los Angeles 6
Auburn Hills 5
Brussels 5
Jiaxing 5
Kunming 5
Orange 5
Washington 5
Ningbo 4
Tappahannock 4
Guangzhou 3
Hefei 3
Helsinki 3
Lanzhou 3
London 3
Norwalk 3
Padova 3
Chengdu 2
Des Moines 2
Dong Ket 2
Jakarta 2
Redwood City 2
Xian 2
Ardabil 1
Baotou 1
Bologna 1
Canaro 1
Changchun 1
Chongqing 1
Formia 1
Fuzhou 1
Haikou 1
Hangzhou 1
Harbin 1
Kilburn 1
Mumbai 1
Munich 1
Navegantes 1
Rome 1
San Francisco 1
San Mateo 1
Shaoxing 1
Taiyuan 1
Taizhou 1
Tomsk 1
Tosagua 1
Totale 1.993
Nome #
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 160
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 159
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 134
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 132
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 117
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 116
Growth hormone excess promotes breast cancer chemoresistance 108
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 108
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 106
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 102
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 93
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 93
Growth hormone induces chemoresistance in breast cancer cells 92
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 87
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 77
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 77
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 76
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 75
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 74
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 70
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kB. 70
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 69
mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures 67
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 65
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 61
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 54
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 50
null 44
null 40
mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures 22
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  20
Totale 2.618
Categoria #
all - tutte 11.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020424 0 0 15 74 38 87 43 50 37 64 7 9
2020/2021364 30 22 30 75 6 35 16 41 10 35 42 22
2021/2022288 7 35 13 2 8 18 14 6 6 29 41 109
2022/2023387 33 41 18 55 64 52 20 26 48 4 12 14
2023/2024209 15 16 8 6 18 37 8 53 5 2 2 39
2024/202575 16 9 50 0 0 0 0 0 0 0 0 0
Totale 2.618